Nucleus accumbens deep-brain stimulation efficacy in ACTH-pretreated rats: alterations in mitochondrial function relate to antidepressant-like effects

作者: Y Kim , S McGee , J K Czeczor , A J Walker , R P Kale

DOI: 10.1038/TP.2016.84

关键词:

摘要: Mitochondrial dysfunction has a critical role in the pathophysiology of mood disorders and treatment response. To investigate this, we established an animal model exhibiting state antidepressant resistance male Wistar rats using 21 days adrenocorticotropic hormone (ACTH) administration (100 μg per day). First, effect ACTH on efficacy imipramine (10 mg kg(-1)) was investigated alongside its prefrontal cortex (PFC) mitochondrial function. Second, examined mood-regulatory actions chronic (7 day) high-frequency nucleus accumbens (NAc) deep-brain stimulation (DBS; 130 Hz, 100 μA, 90 μS) concomitant PFC Antidepressant-like responses were assessed open field test (OFT) forced swim (FST) for both conditions. pretreatment prevented imipramine-mediated improvement mobility during FST (P 0.05). Analyses function revealed that ACTH-treated animals had decreased capacity adenosine triphosphate production compared with controls. In contrast, following NAc DBS demonstrated greater relative to Interestingly, proportion (30%) exhibited heightened locomotor activity OFT exaggerated escape behaviors FST, together general hyperactivity their home-cage settings. More importantly, induction this mania-like phenotype accompanied by overcompensative increased respiration. Manifestation DBS-induced imipramine-resistant highlights potential use elucidating mechanisms dysregulation.

参考文章(40)
Adam J. Walker, Brittany M. Foley, Shari L. Sutor, Jane A. McGillivray, Mark A. Frye, Susannah J. Tye, Peripheral proinflammatory markers associated with ketamine response in a preclinical model of antidepressant-resistance. Behavioural Brain Research. ,vol. 293, pp. 198- 202 ,(2015) , 10.1016/J.BBR.2015.07.026
Cheng-Chen Chang, Shaw-Hwa Jou, Ta-Tsung Lin, Te-Jen Lai, Chin-San Liu, Mitochondria DNA Change and Oxidative Damage in Clinically Stable Patients with Major Depressive Disorder PLOS ONE. ,vol. 10, pp. e0125855- ,(2015) , 10.1371/JOURNAL.PONE.0125855
W. Abdel-Razaq, D. A. Kendall, T. E. Bates, The effects of antidepressants on mitochondrial function in a model cell system and isolated mitochondria. Neurochemical Research. ,vol. 36, pp. 327- 338 ,(2011) , 10.1007/S11064-010-0331-Z
Adam J. Walker, Sandy A. Burnett, Kyoko Hasebe, Jane A. McGillivray, Laura J. Gray, Sean L. McGee, Ken Walder, Michael Berk, Susannah J. Tye, Chronic adrenocorticotrophic hormone treatment alters tricyclic antidepressant efficacy and prefrontal monoamine tissue levels. Behavioural Brain Research. ,vol. 242, pp. 76- 83 ,(2013) , 10.1016/J.BBR.2012.12.033
Martin Picard, Robert-Paul Juster, Bruce S. McEwen, Mitochondrial allostatic load puts the 'gluc' back in glucocorticoids. Nature Reviews Endocrinology. ,vol. 10, pp. 303- 310 ,(2014) , 10.1038/NRENDO.2014.22
Michael Berk, Lesley Berk, Is 'depression' the new 'neurosis'? Australian and New Zealand Journal of Psychiatry. ,vol. 47, pp. 297- 298 ,(2013) , 10.1177/0004867413482495
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K. Reim, Krista L. Lanctôt, A Meta-Analysis of Cytokines in Major Depression Biological Psychiatry. ,vol. 67, pp. 446- 457 ,(2010) , 10.1016/J.BIOPSYCH.2009.09.033
Felicity Ng, Michael Berk, Olivia Dean, Ashley I. Bush, Oxidative stress in psychiatric disorders : evidence base and therapeutic implications The International Journal of Neuropsychopharmacology. ,vol. 11, pp. 851- 876 ,(2008) , 10.1017/S1461145707008401
Rebecca E.S. Anglin, Michael F. Mazurek, Mark A. Tarnopolsky, Patricia I. Rosebush, The mitochondrial genome and psychiatric illness. American Journal of Medical Genetics. ,vol. 159, pp. 749- 759 ,(2012) , 10.1002/AJMG.B.32086